EMFAT
Emerald Mutual Fund Advisers Trust’s United Therapeutics UTHR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $741K | Buy |
2,580
+33
| +1% | +$9.48K | 0.05% | 150 |
|
|
2025
Q1 | $785K | Sell |
2,547
-155
| -6% | -$47.8K | 0.06% | 142 |
|
|
2024
Q4 | $953K | Buy |
2,702
+2,391
| +769% | +$844K | 0.06% | 139 |
|
|
2024
Q3 | $111K | Buy |
+311
| New | +$111K | 0.01% | 219 |
|
|
2023
Q3 | – | Sell |
-501
| Closed | -$111K | – | 255 |
|
|
2023
Q2 | $111K | Sell |
501
-55,402
| -99% | -$12.2M | 0.01% | 227 |
|
|
2023
Q1 | $12.5M | Sell |
55,903
-11,935
| -18% | -$2.67M | 0.74% | 60 |
|
|
2022
Q4 | $18.9M | Sell |
67,838
-34,979
| -34% | -$9.73M | 1.17% | 30 |
|
|
2022
Q3 | $21.5M | Sell |
102,817
-30,846
| -23% | -$6.46M | 1.36% | 14 |
|
|
2022
Q2 | $31.5M | Sell |
133,663
-40,277
| -23% | -$9.49M | 1.83% | 4 |
|
|
2022
Q1 | $31.2M | Sell |
173,940
-16,083
| -8% | -$2.89M | 1.38% | 18 |
|
|
2021
Q4 | $41.1M | Buy |
190,023
+5,940
| +3% | +$1.28M | 1.45% | 13 |
|
|
2021
Q3 | $34M | Sell |
184,083
-206
| -0.1% | -$38K | 1.18% | 26 |
|
|
2021
Q2 | $33.1M | Sell |
184,289
-2,197
| -1% | -$394K | 1.08% | 28 |
|
|
2021
Q1 | $31.2M | Buy |
186,486
+517
| +0.3% | +$86.5K | 1.04% | 24 |
|
|
2020
Q4 | $28.2M | Buy |
185,969
+11,923
| +7% | +$1.81M | 0.98% | 32 |
|
|
2020
Q3 | $17.6M | Buy |
174,046
+209
| +0.1% | +$21.1K | 0.78% | 52 |
|
|
2020
Q2 | $21M | Buy |
173,837
+66,084
| +61% | +$8M | 0.99% | 33 |
|
|
2020
Q1 | $10.2M | Buy |
+107,753
| New | +$10.2M | 0.64% | 56 |
|